Group Leaders

Do you want to shape the scientific direction of SAiGENCI? 

This is a rare opportunity for promising or established cancer research scientists or clinician researchers to join SAIGENCI at the “start-up” phase. You will lead your own research team and your research interests and ambitions will help to shape the long-term scientific direction of the institute.  

We have substantial support from the Federal Government to build research, translation and clinical capability in cancer immunotherapy and cell therapy in South Australia.  We seek clinical academic and cancer research talent from all over the world to join us to create an elite research community with a clear focus on excellence that once established will take its place amongst the most productive and best known cancer research institutes in the world.  We want people with ambition for their own research but also an ability to work in a collegial, multidisciplinary environment.

You will bring a capacity for research that adds to the total cancer research effort in the Adelaide Biomedical Precinct, generating new opportunities for collaboration and research synergy with laboratory and clinical colleagues introducing a new and desirable research endeavour for the Adelaide Biomedical Precinct.

Expressions of interest close July 31 2021.

    Expand
  • We are particularly interested in expressions of interest in the following fields:

    • Cancer Genomics: The genetics and underlying pathological mechanisms of malignancies. How can we improve diagnoses and diagnostic efficiency, and how can we identify patients with a predisposition for the disease or at risk of poor prognosis?   
       
    • Clinical Immunotherapy: Development of existing approaches (Chimeric antigen receptors (CARs)/CAR T cell therapies and checkpoint inhibitors (CPIs)) and novel immunotherapeutic approaches to treat solid and liquid cancers. 
       
    • RNA-based Therapeutics: Building knowledge toward a better understanding of the involvement of/manipulation of microRNAs in malignancy and the broader development and use of RNA technologies as therapies in cancer targeting specific pathways in disease or generating personalised vaccines to cancer.
    • Cancer biology: Elucidation of the mechanisms and causative lesions by which various cancers manifest their phenotype to identify novel therapeutic targets.
       
    • Epigenetics. Development of tools and analytical methods to facilitate the understanding of tumorigenic processes and the influence of factors beyond genetic code, leading to discovery of new targets and development of novel therapies.
       
    • Children’s Cancer Program: Investigation and treatment of childhood cancer including brain tumours and diseases requiring bone marrow transplantation.
       
    • Solid Tumour Program: Cancers of the brain, respiratory system and digestive system. Integration of personalised oncology, experimental therapeutics and early stage clinical trials. 
       
    • Radiation Oncology Program: Translational research programs in Radiation Oncology (in collaboration with the Radiation Oncology Department at the Royal Adelaide Hospital) to leverage the many opportunities for new treatments associated with the establishment in Adelaide in 2024 of the first proton therapy centre in Australia. 
       
    • Artificial Intelligence in Cancer Program: Analysis of large and complex data sets to identify patterns and relationships to support cancer diagnosis, prognosis, personalised therapeutic regimen design, and clinical trial design.

Expressions of interest

We are currently accepting expressions of interest across three levels for five year appointments in the first instance.

Expressions of interest close July 31 2021.

    Expand
  • Level 1 Group Leader – Early Career - Academic Level C

    • Evidence of scientific excellence, ambition and the potential to assume more senior leadership roles into the future. This is likely to be the first leadership (ie lab / group head) role an appointee has held.
  • Level 2 Group Leader – Mid Career - Academic Level D/E

    • An established career with some leadership experience, including as a group or lab head.  
    • Well established on a clear research trajectory with a clearly identified outline of future research plans and aspirations.
  • Level 3 Group Leader – Mentor - Academic Level E

    • A very well-established research career
    • Clear ability to support, mentor and guide the next generation of scientific and/or clinical research leadership.  
    • Strong track record of achievement with the ability to inspire and assist in the development of research vision for less well established groups.

Please complete your expression of interest, including a cover letter, a full academic CV and a written statement. 

    Expand
  • Written statement

    Your written statement should provide a clear outline of your research program and its significance for/contribution towards SAiGENCI’s mission and vision.

    We are looking for original and distinctive research plans which will be highly regarded by peers in the field. You will provide a clear and compelling data-driven narrative about the anticipated impact of your research on human health. 

    Please include the following: 

    1. A specific research plan for the five year period of initial appointment including
      • Lay summary
      • Summary of approach and methodology
      • Indicative budget 
      • Timeframes/milestones
    2. Clinical impact statement on your research plan, including estimation of health outcome benefits in identified population.
    3. Outline of your anticipated publication outputs, including target journals.
    4. Outline of potential grant funding opportunities, including competitive peer reviewed, commercial, philanthropic and other.
    5. Identification and description of potential commercialisation pathways, including evidence, where relevant, of prior engagement.
    6. Evidence of ability to develop and maintain collaborations, including ability to develop and manage interdisciplinary collaborations.
    7. Detail of your requirements for equipment, facility, animal and consumables needs including evidence that the required support structure around the research plan has been considered and realistically assessed.
  • Support for you to join us at SAiGENCI

    As part of the process to welcome new research leaders into SAiGENCI and establish several research groups and necessary research infrastructure, the SAiGENCI team will work with new leaders coming to SAiGENCi, in conjunction with the SAiGENCI Advisory Board, to determine the start up support package.

    This will involve discussions about:

    • provision of financial support for relocation of the leaders and their family 
    • provision of support for Visa nominations and applications where required
    • review of needs for the laboratory/clinical research
    • support to transport biomaterials and equipment to SAiGENCI
    • purchase of essential equipment to resume research in SAiGENCI
    • support to transfer existing grants 
    • provision of resources to recruit additional post-doctoral and/or research support staff for a period of time to enable establishment of the group
    • provision of stipends for HDR students

     

Contact

To discuss these opportunities in more detail please contact
David Lloyd, Interim Director
T: 0418 587 377 
E: david.lloyd@adelaide.edu.au